Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and dopamine quinone

3,4-dihydroxyphenylacetaldehyde has been researched along with dopamine quinone in 2 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)
Trials
(3,4-dihydroxyphenylacetaldehyde)
Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)
Studies
(dopamine quinone)
Trials
(dopamine quinone)
Recent Studies (post-2010) (dopamine quinone)
9905061029

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Baranyi, M; Gagov, H; Kalfin, R; Petkova-Kirova, P; Rakovska, A; Windisch, K1
Goldstein, DS; Isonaka, R; Jinsmaa, Y; Sharabi, Y1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and dopamine quinone

ArticleYear
Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Brain research bulletin, 2017, Volume: 134

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Electric Stimulation; Extracellular Space; Homovanillic Acid; Humans; Male; Mice; Nerve Tissue Proteins; Norepinephrine; Nucleus Accumbens; Peptide Fragments; Phenylethyl Alcohol; Reward; Tissue Culture Techniques

2017
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
    The Journal of pharmacology and experimental therapeutics, 2020, Volume: 372, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; alpha-Synuclein; Antioxidants; Cell Line; Copper; Dopamine; Humans; Monoamine Oxidase; Monophenol Monooxygenase; Oligodendroglia; Oxidation-Reduction; Parkinson Disease; Protein Binding; Protein Conformation; Tolcapone

2020